Mayne Pharma issues notice of intention to terminate the SID
Filed with ASX · · 2 pages · English
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call03 December 2025, Adelaide, Australia: Mayne Pharma Group Limited (ASX: MYX) (Mayne Pharma) refers to its proposed acquisition by Cosette Pharmaceuticals, Inc. (Cosette) by way of a Scheme of Arrangement and its announcement on 21 November 2025 regarding the FIRB condition precedent and the requirement that the parties to consult in good faith under clause 3.7(a)(ii) of the scheme implementation d
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Update on FIRB condition and scheme
- Trading Halt
- Pause in Trading
- Update on status of FIRB approval and second court hearing
- MYX Declaration of Unacceptable Circumstances and Orders
Later from Mayne Pharma
- MYX receives purported termination notice from Cosette
- Mayne Pharma terminates Scheme Implementation Deed
- Termination of Proposed Acquisition of Mayne Pharma
- Market Update
- 2025 AGM presentation and business update
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma